Injective (INJ) is currently priced at $6.13, reflecting an 8.01% increase over the past 24 hours. The daily trading range has been relatively narrow, fluctuating between a low of $5.51 and a high of $6.12, indicating a steady upward momentum.

The trading volume stands at approximately $70.48 million, equating to a volume-to-market cap ratio of 11.48%, which suggests a healthy level of trading activity relative to its market capitalization. Short-term moving averages are indicating bullish momentum, with the 8 SMA at $5.55 showing a gain of 10.51%, while the 21 SMA is at $5.59 with a 9.58% increase.

The 1-hour RSI is currently at 75, suggesting that INJ is approaching overbought territory, while the 7-day RSI at 52 indicates neutral conditions over a longer timeframe. The price has shown a 5.89% increase over the last week, but a notable decline of 16.92% over the past 30 days highlights recent volatility.

Injective's all-time high stands at $52.62, which was reached on March 14, 2024, signifying significant potential for price appreciation if bullish trends persist. The fundamental indicators suggest that while the asset has shown recent gains, the price still remains substantially below its all-time high, providing a potential entry point for investors.

Given the current market conditions, including the bullish short-term indicators and recent price action, the recommendation is a Buy. This rating is supported by the positive 24-hour change and the favorable moving averages, although caution is warranted due to the high RSI indicating potential overbought conditions in the very short term.